List of Excipients in API metoprolol tartrate and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing metoprolol tartrate and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Validus Pharmaceuticals LLC | LOPRESSOR HCT | metoprolol tartrate and hydrochlorothiazide | 30698-463 | CELLULOSE, MICROCRYSTALLINE | |
| Validus Pharmaceuticals LLC | LOPRESSOR HCT | metoprolol tartrate and hydrochlorothiazide | 30698-463 | FD&C BLUE NO. 1 | |
| Validus Pharmaceuticals LLC | LOPRESSOR HCT | metoprolol tartrate and hydrochlorothiazide | 30698-463 | LACTOSE | |
| Validus Pharmaceuticals LLC | LOPRESSOR HCT | metoprolol tartrate and hydrochlorothiazide | 30698-463 | MAGNESIUM STEARATE | |
| Validus Pharmaceuticals LLC | LOPRESSOR HCT | metoprolol tartrate and hydrochlorothiazide | 30698-463 | POLYETHYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing metoprolol tartrate and hydrochlorothiazide
Detailed excipient profiles for metoprolol tartrate and hydrochlorothiazide
Excipient focus: ANHYDROUS LACTOSE
metoprolol tartrate and hydrochlorothiazide drug variants containing ANHYDROUS LACTOSE
metoprolol tartrate and hydrochlorothiazide drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | metoprolol tartrate and hydrochlorothiazide | 27241-301 |
| Validus Pharmaceuticals LLC | metoprolol tartrate and hydrochlorothiazide | 30698-463 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
metoprolol tartrate and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
metoprolol tartrate and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
metoprolol tartrate and hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | metoprolol tartrate and hydrochlorothiazide | 0378-0424 |
| Physicians Total Care Inc | metoprolol tartrate and hydrochlorothiazide | 54868-5400 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C YELLOW NO. 10
metoprolol tartrate and hydrochlorothiazide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | metoprolol tartrate and hydrochlorothiazide | 62756-370 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
metoprolol tartrate and hydrochlorothiazide drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Validus Pharmaceuticals LLC | metoprolol tartrate and hydrochlorothiazide | 30698-463 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C YELLOW NO. 6
metoprolol tartrate and hydrochlorothiazide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | metoprolol tartrate and hydrochlorothiazide | 0378-0424 |
| Physicians Total Care Inc | metoprolol tartrate and hydrochlorothiazide | 54868-5400 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: LACTOSE
metoprolol tartrate and hydrochlorothiazide drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Validus Pharmaceuticals LLC | metoprolol tartrate and hydrochlorothiazide | 30698-463 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
metoprolol tartrate and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | metoprolol tartrate and hydrochlorothiazide | 27241-301 |
| Sun Pharmaceutical Industries Inc | metoprolol tartrate and hydrochlorothiazide | 62756-370 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
metoprolol tartrate and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
metoprolol tartrate and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
metoprolol tartrate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Validus Pharmaceuticals LLC | metoprolol tartrate and hydrochlorothiazide | 30698-463 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POVIDONE
metoprolol tartrate and hydrochlorothiazide drug variants containing POVIDONE
metoprolol tartrate and hydrochlorothiazide drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | metoprolol tartrate and hydrochlorothiazide | 27241-301 |
| Sun Pharmaceutical Industries Inc | metoprolol tartrate and hydrochlorothiazide | 62756-370 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
metoprolol tartrate and hydrochlorothiazide drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | metoprolol tartrate and hydrochlorothiazide | 27241-301 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing POVIDONE K30
Excipient focus: POWDERED CELLULOSE
metoprolol tartrate and hydrochlorothiazide drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | metoprolol tartrate and hydrochlorothiazide | 27241-301 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing POWDERED CELLULOSE
Excipient focus: PROPYLENE GLYCOL
metoprolol tartrate and hydrochlorothiazide drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Validus Pharmaceuticals LLC | metoprolol tartrate and hydrochlorothiazide | 30698-463 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
metoprolol tartrate and hydrochlorothiazide drug variants containing SILICON DIOXIDE
metoprolol tartrate and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
metoprolol tartrate and hydrochlorothiazide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | metoprolol tartrate and hydrochlorothiazide | 0378-0424 |
| Physicians Total Care Inc | metoprolol tartrate and hydrochlorothiazide | 54868-5400 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
metoprolol tartrate and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | metoprolol tartrate and hydrochlorothiazide | 27241-301 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
metoprolol tartrate and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
metoprolol tartrate and hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | metoprolol tartrate and hydrochlorothiazide | 0378-0424 |
| Ajanta Pharma USA Inc | metoprolol tartrate and hydrochlorothiazide | 27241-301 |
| Physicians Total Care Inc | metoprolol tartrate and hydrochlorothiazide | 54868-5400 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
metoprolol tartrate and hydrochlorothiazide drug variants containing STARCH, CORN
metoprolol tartrate and hydrochlorothiazide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | metoprolol tartrate and hydrochlorothiazide | 27241-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
metoprolol tartrate and hydrochlorothiazide drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Validus Pharmaceuticals LLC | metoprolol tartrate and hydrochlorothiazide | 30698-463 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing STEARIC ACID
Excipient focus: SUCROSE
metoprolol tartrate and hydrochlorothiazide drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Validus Pharmaceuticals LLC | metoprolol tartrate and hydrochlorothiazide | 30698-463 |
| >Company | >Ingredient | >NDC |
metoprolol tartrate and hydrochlorothiazide drug variants not containing SUCROSE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links